跳至主要内容
临床试验/NCT02679053
NCT02679053已完成不适用

Aerobic Exercise as add-on Treatment for Inpatients With Depression: Effects and Biomarkers

University Hospital, Basel, Switzerland2 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2013年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
49
试验地点
2
主要终点
Depressive Symptoms self rated

研究概览

简要总结

The aim of the study is to evaluate the effect of 6 weeks of aerobic endurance exercise as adon treatment for moderately to severely depressed inpatients. Endpoints are symptom severity, psychological variables, cognitive symptoms, sleep, hypothalamic-pituitary-adrenal axis (HPA-axis), Brain-derived neurotrophic factor (BDNF) and heartrate variability (HRV).

Amendment 1 (Nov. 2016): additional evaluation of TNF-alpha at baseline, +2 weeks and post (+6weeks) in already existing blood samples.

详细描述

Patients are randomly assigned to the intervention group (IG) or control group (CG). The IG will train three times per week on indoor bicycles at 60 to 75% of maximal heartrate aiming at a weekly total of 17.5kcal/kg bodyweight for 6 consecutive weeks. The exercise will take place under supervision. CG will absolve a basic stretching and mobilisation program 3 times per week, also under supervision for 6 consecutive weeks. At the end of every week physical fitness is evaluated by the queens step test. No other activities with moderate or high intensity are allowed throughout the intervention time.

All patients will participate in the multimodal treatment program of the depression ward, which includes pharmacotherapy, psychotherapy and specialized therapies such as art therapy and ergotherapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Inpatient treatment on the Depression ward
  • •International Classification of Diseases (ICD)-10: F32, F33 or F31
  • •HDRS-17>16 Points
  • •written informed consent

排除标准

  • •Any physical condition that prohibits endurance exercise
  • •3 or more cardiovascular risk factors (hypertonia, family history, smoking, hypertriglyceridemia, diabetes)
  • •pathological ECG
  • •BMI > 35 kg/m2
  • •Pregnancy
  • •acute suicidal Ideation
  • •comorbid substance dependence (except nicotine)
  • •Major comorbid psychiatric disorder
  • •regular high intensity exercise prior to treatment

研究组 & 干预措施

Exercise (IG)

Experimental

Aerobic exercise three times per week on indoor bicycles at 60 to 75% of maximal heartrate aiming at a weekly total of 17.5kcal/kg bodyweight for 6 consecutive weeks. The exercise will take place under supervision. At the end of every week physical fitness is evaluated by the queens step test.No other activities with moderate or high intensity are allowed throughout the intervention time.

干预措施: Aerobic exercise (Behavioral)

Control (CG)

Placebo Comparator

Basic stretching and mobilisation program 3 times per week each for approx. 40 minutes, also under supervision for 6 consecutive weeks. At the end of every week physical fitness is evaluated by the queens step test.At the end of every week physical fitness is evaluated by the queens step test.No other activities with moderate or high intensity are allowed throughout the intervention time.

干预措施: Placebo control (Behavioral)

结局指标

主要结局

Depressive Symptoms self rated

时间窗: Baseline (pre), 1 week, 2 weeks, 6 weeks (post), 6 months (followup)

Change in Score of Hamilton Depression Rating Scale (HDRS-17) from baseline until 6 months follow-up

Depressive Symptoms physician rated

时间窗: Baseline (pre), 1 week, 2 weeks, 6 weeks (post), 6 months (follow-up)

Change in Score of Beck Depression Inventory (BDI) from baseline until 6 months follow-up

次要结局

  • Psychological symptoms(Baseline (pre), 6 weeks (post), 6 months (follow-up))
  • Sleep (Polysomnography)(Baseline (pre), 6 weeks (post))
  • Social stress - cortisol(Baseline (pre), 6 weeks (post))
  • Mental Toughness(Baseline (pre), 6 weeks (post), 6 months (followup))
  • Cognition(Baseline (pre), 6 weeks (post), 6 months (followup))
  • Physical activity(Baseline (pre), 6 months (follow-up))
  • TNF-Alpha (additional value assessed/Amendment 1)(Baseline (pre), 2 weeks (post), 6 weeks (post))
  • Cortisol awakening response (CAR)(Baseline (pre), 2 weeks, 6 weeks (post), 6 months (follow-up))
  • Sleep (Subjective sleep Quality)(Baseline (pre), 6 weeks (post), 6 months (followup))
  • Social stress - heartrate(Baseline (pre), 6 weeks (post))
  • Brain derived neurotrophic factor (Serum-BDNF)(Baseline (pre), 2 weeks, 6 weeks (post), 6 months (followup))
  • Sleep related personality traits(Baseline (pre), 6 weeks (post), 6 months (followup))
  • Body Mass Index (BMI)(Baseline (pre), 6 weeks (post), 6 months (followup))
  • Resting Heartrate (HR)(Baseline (pre), 6 weeks (post), 6 months (followup))
  • Blood Pressure (BP)(Baseline (pre), 6 weeks (post), 6 months (followup))

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验